N-acetylcysteine yields sex-specific efficacy for cue-induced reinstatement of nicotine seeking

Julianna Goenaga, Gregory L. Powell, Jonna M. Leyrer-Jackson, Jose Piña, Sandy Phan, Alesia V. Prakapenka, Stephanie V. Koebele, Mark D. Namba, Erin A. McClure, Heather Bimonte-Nelson, Cassandra Gipson-Reichardt

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Women report greater craving during certain phases of the menstrual cycle. As well, research indicates that pharmacotherapies for smoking may be less efficacious in women compared with men, which may be due to interactions with natural fluctuations in ovarian hormone levels. N-Acetylcysteine (NAC) is a glutamatergic compound that has shown some efficacy in treating substance use disorders and aids in the prevention of relapse. However, it is unclear whether NAC has sex-specific effectiveness for nicotine relapse treatment. Given that NAC has shown promise to reduce nicotine reinstatement in preclinical models using male rats, the exploration of potential sex differences in the efficacy of NAC is warranted. Using a rat model, we first investigated the ability of NAC treatment (100 mg/kg, ip) during nicotine withdrawal with extinction training to reduce cue-induced nicotine seeking in male and female rats. Next, we assessed whether NAC's effects were estrous cycle–dependent for female rats. Results show that following NAC treatment during extinction, reinstatement of nicotine seeking was significantly decreased in males but not females, indicating a sex-specific effect of NAC. Furthermore, for females, both vehicle- and NAC-treated groups significantly reinstated nicotine-seeking behavior compared with extinction, regardless of estrous cycle phase. These results suggest that NAC is inefficacious in reducing nicotine relapse in females regardless of estrous cycle phase at the dose evaluated here. These collective findings could have important clinical implications for use and efficacy of NAC as a pharmacotherapy for freely cycling women smokers.

Original languageEnglish (US)
JournalAddiction Biology
DOIs
StatePublished - Jan 1 2019

Fingerprint

Acetylcysteine
Nicotine
Cues
Estrous Cycle
Recurrence
Drug Therapy
Aptitude
Menstrual Cycle
Secondary Prevention
Sex Characteristics
Substance-Related Disorders
Therapeutics
Smoking
Hormones

Keywords

  • estrous cycle
  • N-acetylcysteine
  • nicotine
  • sex differences
  • smoking

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Pharmacology
  • Psychiatry and Mental health

Cite this

N-acetylcysteine yields sex-specific efficacy for cue-induced reinstatement of nicotine seeking. / Goenaga, Julianna; Powell, Gregory L.; Leyrer-Jackson, Jonna M.; Piña, Jose; Phan, Sandy; Prakapenka, Alesia V.; Koebele, Stephanie V.; Namba, Mark D.; McClure, Erin A.; Bimonte-Nelson, Heather; Gipson-Reichardt, Cassandra.

In: Addiction Biology, 01.01.2019.

Research output: Contribution to journalArticle

Goenaga, J, Powell, GL, Leyrer-Jackson, JM, Piña, J, Phan, S, Prakapenka, AV, Koebele, SV, Namba, MD, McClure, EA, Bimonte-Nelson, H & Gipson-Reichardt, C 2019, 'N-acetylcysteine yields sex-specific efficacy for cue-induced reinstatement of nicotine seeking', Addiction Biology. https://doi.org/10.1111/adb.12711
Goenaga, Julianna ; Powell, Gregory L. ; Leyrer-Jackson, Jonna M. ; Piña, Jose ; Phan, Sandy ; Prakapenka, Alesia V. ; Koebele, Stephanie V. ; Namba, Mark D. ; McClure, Erin A. ; Bimonte-Nelson, Heather ; Gipson-Reichardt, Cassandra. / N-acetylcysteine yields sex-specific efficacy for cue-induced reinstatement of nicotine seeking. In: Addiction Biology. 2019.
@article{a1494bbfbd1d4e6782e6e71a16859ca5,
title = "N-acetylcysteine yields sex-specific efficacy for cue-induced reinstatement of nicotine seeking",
abstract = "Women report greater craving during certain phases of the menstrual cycle. As well, research indicates that pharmacotherapies for smoking may be less efficacious in women compared with men, which may be due to interactions with natural fluctuations in ovarian hormone levels. N-Acetylcysteine (NAC) is a glutamatergic compound that has shown some efficacy in treating substance use disorders and aids in the prevention of relapse. However, it is unclear whether NAC has sex-specific effectiveness for nicotine relapse treatment. Given that NAC has shown promise to reduce nicotine reinstatement in preclinical models using male rats, the exploration of potential sex differences in the efficacy of NAC is warranted. Using a rat model, we first investigated the ability of NAC treatment (100 mg/kg, ip) during nicotine withdrawal with extinction training to reduce cue-induced nicotine seeking in male and female rats. Next, we assessed whether NAC's effects were estrous cycle–dependent for female rats. Results show that following NAC treatment during extinction, reinstatement of nicotine seeking was significantly decreased in males but not females, indicating a sex-specific effect of NAC. Furthermore, for females, both vehicle- and NAC-treated groups significantly reinstated nicotine-seeking behavior compared with extinction, regardless of estrous cycle phase. These results suggest that NAC is inefficacious in reducing nicotine relapse in females regardless of estrous cycle phase at the dose evaluated here. These collective findings could have important clinical implications for use and efficacy of NAC as a pharmacotherapy for freely cycling women smokers.",
keywords = "estrous cycle, N-acetylcysteine, nicotine, sex differences, smoking",
author = "Julianna Goenaga and Powell, {Gregory L.} and Leyrer-Jackson, {Jonna M.} and Jose Pi{\~n}a and Sandy Phan and Prakapenka, {Alesia V.} and Koebele, {Stephanie V.} and Namba, {Mark D.} and McClure, {Erin A.} and Heather Bimonte-Nelson and Cassandra Gipson-Reichardt",
year = "2019",
month = "1",
day = "1",
doi = "10.1111/adb.12711",
language = "English (US)",
journal = "Addiction Biology",
issn = "1355-6215",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - N-acetylcysteine yields sex-specific efficacy for cue-induced reinstatement of nicotine seeking

AU - Goenaga, Julianna

AU - Powell, Gregory L.

AU - Leyrer-Jackson, Jonna M.

AU - Piña, Jose

AU - Phan, Sandy

AU - Prakapenka, Alesia V.

AU - Koebele, Stephanie V.

AU - Namba, Mark D.

AU - McClure, Erin A.

AU - Bimonte-Nelson, Heather

AU - Gipson-Reichardt, Cassandra

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Women report greater craving during certain phases of the menstrual cycle. As well, research indicates that pharmacotherapies for smoking may be less efficacious in women compared with men, which may be due to interactions with natural fluctuations in ovarian hormone levels. N-Acetylcysteine (NAC) is a glutamatergic compound that has shown some efficacy in treating substance use disorders and aids in the prevention of relapse. However, it is unclear whether NAC has sex-specific effectiveness for nicotine relapse treatment. Given that NAC has shown promise to reduce nicotine reinstatement in preclinical models using male rats, the exploration of potential sex differences in the efficacy of NAC is warranted. Using a rat model, we first investigated the ability of NAC treatment (100 mg/kg, ip) during nicotine withdrawal with extinction training to reduce cue-induced nicotine seeking in male and female rats. Next, we assessed whether NAC's effects were estrous cycle–dependent for female rats. Results show that following NAC treatment during extinction, reinstatement of nicotine seeking was significantly decreased in males but not females, indicating a sex-specific effect of NAC. Furthermore, for females, both vehicle- and NAC-treated groups significantly reinstated nicotine-seeking behavior compared with extinction, regardless of estrous cycle phase. These results suggest that NAC is inefficacious in reducing nicotine relapse in females regardless of estrous cycle phase at the dose evaluated here. These collective findings could have important clinical implications for use and efficacy of NAC as a pharmacotherapy for freely cycling women smokers.

AB - Women report greater craving during certain phases of the menstrual cycle. As well, research indicates that pharmacotherapies for smoking may be less efficacious in women compared with men, which may be due to interactions with natural fluctuations in ovarian hormone levels. N-Acetylcysteine (NAC) is a glutamatergic compound that has shown some efficacy in treating substance use disorders and aids in the prevention of relapse. However, it is unclear whether NAC has sex-specific effectiveness for nicotine relapse treatment. Given that NAC has shown promise to reduce nicotine reinstatement in preclinical models using male rats, the exploration of potential sex differences in the efficacy of NAC is warranted. Using a rat model, we first investigated the ability of NAC treatment (100 mg/kg, ip) during nicotine withdrawal with extinction training to reduce cue-induced nicotine seeking in male and female rats. Next, we assessed whether NAC's effects were estrous cycle–dependent for female rats. Results show that following NAC treatment during extinction, reinstatement of nicotine seeking was significantly decreased in males but not females, indicating a sex-specific effect of NAC. Furthermore, for females, both vehicle- and NAC-treated groups significantly reinstated nicotine-seeking behavior compared with extinction, regardless of estrous cycle phase. These results suggest that NAC is inefficacious in reducing nicotine relapse in females regardless of estrous cycle phase at the dose evaluated here. These collective findings could have important clinical implications for use and efficacy of NAC as a pharmacotherapy for freely cycling women smokers.

KW - estrous cycle

KW - N-acetylcysteine

KW - nicotine

KW - sex differences

KW - smoking

UR - http://www.scopus.com/inward/record.url?scp=85061255956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061255956&partnerID=8YFLogxK

U2 - 10.1111/adb.12711

DO - 10.1111/adb.12711

M3 - Article

JO - Addiction Biology

JF - Addiction Biology

SN - 1355-6215

ER -